De novo synthesis of the bacterial 2-amino-2,6-dideoxy sugar building blocks D-Fucosamine, D-bacillosamine, and D-xylo-6-deoxy-4-ketohexosamine

Organic Letters

Volumn 14, Issue 18, 2012, Pages 4954-4957

  Leonori, Daniele ^a   Seeberger, Peter H ^b  

^a MAX PLANCK INSTITUTE OF COLLOIDS AND INTERFACES   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 FUCOSAMINE; 2-FUCOSAMINE; 4 DEOXYNEOSAMINE C; 4-DEOXYNEOSAMINE C; ALDEHYDE; DRUG DERIVATIVE; FUCOSE; HEXOSAMINE; MONOSACCHARIDE; POLYSACCHARIDE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; STEREOISOMERISM; SYNTHESIS;

ALDEHYDES; FUCOSE; HEXOSAMINES; MOLECULAR STRUCTURE; MONOSACCHARIDES; POLYSACCHARIDES; STEREOISOMERISM;

EID: 84868258404     PISSN: 15237060     EISSN: 15237052     Source Type: Journal    
DOI: 10.1021/ol3023227     Document Type: Article

References (55)

1. (a) For selected reviews, see: (a) Mariño, K.; Bones, J.; Kattla, J. J.; Rudd, P. M. Nat. Chem. 2010, 6, 713
2. (b) Arnold, J. N.; Wormald,M. R.; Sim, R. B.; Rudd, P. M.; Dwek, R. A. Annu. Rev. Immunol. 2007, 25, 21.
3. For selected reviews, see: (a) Dube, D. H.; Bertozzi, C. R. Nat. Rev. Drug Discovery 2005, 4, 477
4. (b) Stallforth, P.; Lepenies, B.; Adibekian, A.; Seeberger, P. H. J. Med. Chem. 2009, 52, 5561
5. (c) Dube, D. H.; Champasa, K.; Wang, B. Chem. Commun. 2011, 47, 87
6. (d) Boltje, T. J.; Buskas, T.; Boons, G.-J. Nat. Chem. 2009, 1, 6111.
7. For selected examples, see: (a)Banerjee, A.;Wang, R.; Supernavage, S. L.;Ghosh, S. K.; Parker, J.;Ganesh,N. F.;Wang, P.G.;Gulati, S.;Rice, P. A. J. Exp. Med. 2002, 196, 147
8. (b) Power, P.M.; Ku, S.C.;Rutter,K.; Warren,M. J.; Limnios, E. A.;Tapsall, J.W.; Jennings,M.P. Infect. Immun. 2007, 75, 3202.
9. For selected examples, see: (a) van Sorge, N. M.; Bleumink, N. M.; van Vliet, S. J.; Saeland, E.; van der Pol, W. L.; van Kooyk, Y.; van Putten, J. P. Cell. Microbiol. 2009, 11, 1768
10. (b) Verma, A.; Arora, S. K.; Kuravi, S. K.; Ramphal, R. Infect. Immun. 2005, 73, 8237.
11. For selected reviews, see: (a) Zhu, X. M.; Schmidt, R. R. Angew. Chem., Int. Ed. 2009, 48, 1900
12. (b) Codee, J. D. C.; Litjens, R.; van den Bos, L. J.; Overkleeft, H. S.; van der Marel, G. A. Chem. Soc. Rev. 2005, 34, 769
13. (c) Boons, G.-J.; Demchenko, A. V. Chem. Rev. 2000, 100, 4539.
14. For recent examples from our laboratory, see: (a) Yang, Y.; Martin, C. E.; Seeberger, P. H. Chem. Sci. 2012, 3, 896
15. (b) Martin, C. E.; Weishaupt, M. W.; Seeberger, P. H. Chem. Commun. 2011, 47, 10260.
16. (a) Smedley, J. G.; Jewell, E.; Roguskie, J.; Horzempa, J.; Syboldt, A.; Stolz, D. B.; Castric, P. Infect. Immun. 2005, 73, 7922.
17. For evidence that the glycosylation aids in establishment of infection in mouse model, see: (b) Castric, P.; Cassels, F. J.; Carlson, R. W. J. Biol. Chem. 2001, 276, 26479
18. (c) Chamot-Rooke, J.; Rousseau, B.; Lanternier, F.; Mikaty, G.; Mairey, E.; Malosse, C.; Bouchoux, G.; Pelicic, V.; Camoin, L.; Nassif, X.; Dumenil, G. Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 14783.
19. Fucosamine is also present in the glycon of Elsamicin A; see: (e) Sugawara, K.; Tsunakawa, M.; Konishi, M.; Kawaguchi, J. J. Org. Chem. 1987, 52, 996.
20. Also present in Neocarzinostatin; see: (f) Myers, A. G.; Liang, J.; Hammond, M.; Harrington, P. M.; Wu, Y.; Kuo, E. Y. J. Am. Chem. Soc. 1998, 120, 5319.
21. (a) Banerjee, A.; Ghosh, S. K. Mol. Cell. Biochem. 2003, 253, 179.
22. For evidence that the glycosylation is implicated in adherence, blocking immune response, and spread of infection, see: (b) Power, P. M.; Seib, K. L.; Jennings, M. P. Biochem. Biophys. Res. Commun. 2006, 347, 904.
23. Bacillosamine is also present in the glycan of Clycocinnamoylspermidines; see: (c) Ellestad, G. A.; Cosulich, D. B.; Broschard, R. W.; Martin, J. H.; Kunstmann,M. P.; Morton, G. O.; Lancaster, J. E.; Fulmor, W.; Lovell, F. M. J. Am. Chem. Soc. 1978, 100, 2515.
24. (a) Siemieniuk, R. A. C.; Gregson, D. B.; Gill, M. J. BMC Infect. Dis. 2011, 11, 314.
25. DKH is also present in the lypopolysaccharide of Yerisinia pestis; see: (b) Pinta, E.; Duda, K. A.; Hanuszkiewicz, A.; Kaczynski, Z.; Lindner, B.; Miller, W. L.; Hyytiäinen, H.; Vogel, C.; Borowski, S.; Kasperkiewicz, K.; Lam, J. S.; Radziejewska-Lebrecht, J.; Skurnik, M.; Holst, O. Chem.-Eur. J. 2009, 15, 9747.
26. For selected synthesis of fucosamine and bacillosamine starting from galactosamine derivatives, see: (a) Liav, A.; Hildesheim, J.; Zehavi, U.; Sharon, N. Carbohydr. Res. 1974, 33, 217
27. (b) Busca, P.; Martin, O. R. Tetrahedron Lett. 2004, 45, 4433
28. (c) Jones, G. B.; Lin, Y.; Xiao, Z.; Kappenb, L.; Goldberg, I. H. Bioorg. Med. Chem. 2007, 15, 784
29. (d) Weerapana, E.; Glover, K. J.; Chen, M. M.; Imperiali, B. J. Am. Chem. Soc. 2005, 127, 13766
30. (e) Amin, M. N.; Ishiwata, A.; Ito, Y. Carbohydr. Res. 2006, 341, 1922.
31. For a synthesis of bacillosamine starting from fucose, see: (f) Bedini, E.; Esposito, D.; Parrilli, M. Synlett 2006, 6, 825.
32. For selected reviews on de novo carbohydrate synthesis, see: (a) Schmidt, R. R. Pure Appl. Chem. 1987, 59, 415
33. (b) Kirschning, A.; Jesberger, M.; Schöning, K.-U. Synthesis 2001, 4, 507
34. (c) Hemeon, I.; Bennet, A. J. Synthesis 2007, 13, 1899.
35. For selected examples on de novo carbohydrate synthesis, see: (d) Voigt, B.; Scheffler, U.; Mahrwald, R. Chem. Commun. 2012, 48, 5304
36. (e) Crich, D.; Navuluri, C. Org. Lett. 2011, 13, 6288
37. (f) Lorpitthaya, R.; Suryawanshi, S. B.; Wang, S.; Pasunooti, K. K.; Cai, S.; Ma, J.; Liu, X.-W. Angew. Chem., Int. Ed. 2011, 123, 12260
38. (g) Northrup, A. B.; MacMillan, D. W. C. Science 2004, 305, 1752
39. (h) Babu, R. S.; Zhou, M.; O'Doherty, G. A. J. Am. Chem. Soc. 2004, 126, 3428
40. (i) Enders, D.; Grondal, C. Angew. Chem., Int. Ed. 2005, 44, 1210.
41. For recent de novo carbohydrate syntheses from our laboratory, see: (a) Calin, O.; Pragani, R.; Seeberger, P. H. J. Org. Chem. 2012, 77, 870
42. (b) Pragani, R.; Seeberger, P. H. J. Am. Chem. Soc. 2011, 133, 102
43. Garner, P. Tetrahedron Lett. 1984, 25, 5855.
44. (a) Cram, D. J.; Kopecky, K. R. J. Am. Chem. Soc. 1959, 81, 2748.
45. For a recent review, see (b) O'Brien, A. G. Tetrahedron 2011, 67, 9639.
46. For selected studies on the addition of alkynes to Garner aldehyde, see: (a) Zhang, X.; van der Donk, W. A. J. Am. Chem. Soc. 2007, 129, 2212
47. (b) Garner, P.; Park, J. M.; Malecki, E. J. Org. Chem. 1988, 53, 4395.
48. For a review, see: (c) Liang, X.; Andersch, J.; Bols, M. J. Chem. Soc., Perkin Trans. 1 2001, 2136.
49. Dess, D. B.; Martin, J. C. J. Org. Chem. 1983, 48, 4155.
50. For a discussion of stereocontrolled reactions of acyclic allylic ethers, see: (a) Cha, J. K.; Kim, N.-S. Chem. Rev. 1995, 95, 1761.
51. For selected examples, see: (b) Cha, J. K.; Christ, W. J.; Kishi, Y. Tetrahedron Lett. 1983, 24, 3943
52. (c) Karjalainen, O. K.; Koskinen, A. M. P. Org. Biomol. Chem. 2011, 9, 1231.
53. Oxidation of 5b under Swern conditions resulted in partial epimerization at C2, and monosaccharide 21 was isolated. For a synthetic discussion of epimerizable N-protected α-amino aldehydes, see: Myers, A. G.; Zhong, B.; Movassaghi, M.; Kung, D. V.; Lanman, B. A.; Kwon, S. Tetrahedron Lett. 2000, 41, 1359.
54. Snapper, C.; Mond, J. J. Immunol. 1996, 157, 2229.
55. Plé, K.; Chwalek, M.; Voutquenne-Nazabadioko, L. Tetrahedron 2005, 61, 4347.